Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis

Objectives: N6-methylladenosine (m6A) modification has not been fully studied in atherosclerosis. The objectives of this study were to investigate differentially expressed m6A methylated peaks and mRNAs, along with the regulatory role of methyltransferase 3 (METTL3) in pathological processes of athe...

Full description

Bibliographic Details
Main Authors: Yaqing Zhou, Rongli Jiang, Yali Jiang, Yahong Fu, Yerbolat Manafhan, Jinfu Zhu, Enzhi Jia
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/19/2980
_version_ 1797479994200424448
author Yaqing Zhou
Rongli Jiang
Yali Jiang
Yahong Fu
Yerbolat Manafhan
Jinfu Zhu
Enzhi Jia
author_facet Yaqing Zhou
Rongli Jiang
Yali Jiang
Yahong Fu
Yerbolat Manafhan
Jinfu Zhu
Enzhi Jia
author_sort Yaqing Zhou
collection DOAJ
description Objectives: N6-methylladenosine (m6A) modification has not been fully studied in atherosclerosis. The objectives of this study were to investigate differentially expressed m6A methylated peaks and mRNAs, along with the regulatory role of methyltransferase 3 (METTL3) in pathological processes of atherosclerosis. Methods: The pathological models of human coronary artery smooth muscle cells (HCASMCs) were induced in vitro. The differentially expressed mRNAs and m6A peaks were identified by RNA-Seq and meRIP-Seq. The potential mechanisms were analyzed via bioinformatic assays. Methylases expression was tested by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting (WB) in HCASMCs, and by immunohistochemical assays in 40 human coronary arteries. The knockdown of METTL3 expression in cells was performed by siRNA transfection, and cell proliferation and migration were detected after transfection. Results: We identified 5121 m6A peaks and 883 mRNAs that were expressed differentially in the pathological processes of HCASMCs. Bioinformatic analyses showed that the different m6A peaks were associated with cell growth and cell adhesion, and the 883 genes showed that the extracellular matrix and PI3K/AKT pathway regulate the processes of HCASMCs. Additionally, 10 hub genes and 351 mRNAs with differential methylation and expression levels were found. METTL3 was upregulated in the arteries with atherosclerotic lesions and in the proliferation and migration model of HCASMCs, and pathological processes of HCASMCs could be inhibited by the knockdown of METTL3. The mechanisms behind regulation of migration and proliferation reduced by siMETTL3 are concerned with protein synthesis and energy metabolism. Conclusions: These results revealed a new m6A epigenetic method to regulate the progress of atherosclerosis, which suggest approaches for potential therapeutic interventions that target METTL3 for the prevention and treatment of coronary artery diseases.
first_indexed 2024-03-09T21:54:45Z
format Article
id doaj.art-551ec80de8a8441da3433c331d6d54e2
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T21:54:45Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-551ec80de8a8441da3433c331d6d54e22023-11-23T20:00:34ZengMDPI AGCells2073-44092022-09-011119298010.3390/cells11192980Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in AtherosclerosisYaqing Zhou0Rongli Jiang1Yali Jiang2Yahong Fu3Yerbolat Manafhan4Jinfu Zhu5Enzhi Jia6Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300, Nanjing 210029, ChinaDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300, Nanjing 210029, ChinaThe Friendship Hospital of Ili Kazakh Autonomous Prefecture,Ili & Jiangsu Joint Institute of Health, Yining 835000, ChinaDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300, Nanjing 210029, ChinaDepartment of Hypertension, Yili Friendship Hospital, Stalin Road 92, Yining 835000, ChinaDepartment of Cardiovascular Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, ChinaDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300, Nanjing 210029, ChinaObjectives: N6-methylladenosine (m6A) modification has not been fully studied in atherosclerosis. The objectives of this study were to investigate differentially expressed m6A methylated peaks and mRNAs, along with the regulatory role of methyltransferase 3 (METTL3) in pathological processes of atherosclerosis. Methods: The pathological models of human coronary artery smooth muscle cells (HCASMCs) were induced in vitro. The differentially expressed mRNAs and m6A peaks were identified by RNA-Seq and meRIP-Seq. The potential mechanisms were analyzed via bioinformatic assays. Methylases expression was tested by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting (WB) in HCASMCs, and by immunohistochemical assays in 40 human coronary arteries. The knockdown of METTL3 expression in cells was performed by siRNA transfection, and cell proliferation and migration were detected after transfection. Results: We identified 5121 m6A peaks and 883 mRNAs that were expressed differentially in the pathological processes of HCASMCs. Bioinformatic analyses showed that the different m6A peaks were associated with cell growth and cell adhesion, and the 883 genes showed that the extracellular matrix and PI3K/AKT pathway regulate the processes of HCASMCs. Additionally, 10 hub genes and 351 mRNAs with differential methylation and expression levels were found. METTL3 was upregulated in the arteries with atherosclerotic lesions and in the proliferation and migration model of HCASMCs, and pathological processes of HCASMCs could be inhibited by the knockdown of METTL3. The mechanisms behind regulation of migration and proliferation reduced by siMETTL3 are concerned with protein synthesis and energy metabolism. Conclusions: These results revealed a new m6A epigenetic method to regulate the progress of atherosclerosis, which suggest approaches for potential therapeutic interventions that target METTL3 for the prevention and treatment of coronary artery diseases.https://www.mdpi.com/2073-4409/11/19/2980atherosclerosissmooth muscle cellRNA-SeqmeRIP-SeqMETTL3
spellingShingle Yaqing Zhou
Rongli Jiang
Yali Jiang
Yahong Fu
Yerbolat Manafhan
Jinfu Zhu
Enzhi Jia
Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
Cells
atherosclerosis
smooth muscle cell
RNA-Seq
meRIP-Seq
METTL3
title Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
title_full Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
title_fullStr Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
title_full_unstemmed Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
title_short Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
title_sort exploration of n6 methyladenosine profiles of mrnas and the function of mettl3 in atherosclerosis
topic atherosclerosis
smooth muscle cell
RNA-Seq
meRIP-Seq
METTL3
url https://www.mdpi.com/2073-4409/11/19/2980
work_keys_str_mv AT yaqingzhou explorationofn6methyladenosineprofilesofmrnasandthefunctionofmettl3inatherosclerosis
AT ronglijiang explorationofn6methyladenosineprofilesofmrnasandthefunctionofmettl3inatherosclerosis
AT yalijiang explorationofn6methyladenosineprofilesofmrnasandthefunctionofmettl3inatherosclerosis
AT yahongfu explorationofn6methyladenosineprofilesofmrnasandthefunctionofmettl3inatherosclerosis
AT yerbolatmanafhan explorationofn6methyladenosineprofilesofmrnasandthefunctionofmettl3inatherosclerosis
AT jinfuzhu explorationofn6methyladenosineprofilesofmrnasandthefunctionofmettl3inatherosclerosis
AT enzhijia explorationofn6methyladenosineprofilesofmrnasandthefunctionofmettl3inatherosclerosis